Minerva Neurosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Minerva Neurosciences, Inc. (NERV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 213.62 thousand shares for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2017-11-06
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-09-30 was 22.50K shares.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-06-30 was 191.12K shares.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-03-31 was 0.00 shares.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2016-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2015 was 571.97K shares, a 4.88% increase from fiscal 2014.
- Minerva Neurosciences, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2014 was 545.35K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2017-09-30 | 22.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | 213.62K shares derived: sum of 2 quarters · filed 2017-11-06 | 213.62K shares 10-Q · filed 2017-11-06 | |
| 2017-06-30 | 191.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 191.12K shares 10-Q · filed 2017-08-03 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-04 | |||
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 0.00 shares derived: sum of 2 quarters · filed 2016-11-03 | 0.00 shares 10-Q · filed 2016-11-03 | 519.67K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 0.00 shares 10-Q · filed 2016-08-04 | 519.67K shares derived: sum of 3 quarters · filed 2016-08-04 | 551.97K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-03 | 519.67K shares derived: sum of 2 quarters · filed 2016-05-03 | 551.97K shares derived: sum of 3 quarters · filed 2016-05-03 | 551.97K shares derived: sum of 4 quarters · filed 2016-05-03 |
| 2015-12-31 | 519.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 551.97K shares derived: sum of 2 quarters · filed 2016-03-14 | 551.97K shares derived: sum of 3 quarters · filed 2016-03-14 | 571.97K shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 32.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 32.30K shares derived: sum of 2 quarters · filed 2015-11-05 | 52.30K shares 10-Q · filed 2015-11-05 | |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | 20.00K shares 10-Q · filed 2015-08-05 | ||
| 2015-03-31 | 20.00K shares 10-Q · filed 2015-05-07 | |||
| 2014-12-31 | 545.35K shares 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |